New York City, NY -- (SBWIRE) -- 01/16/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Pain Therapeutics, Inc. (NASDAQ:PTIE), Document Security Systems, Inc. (NYSEMKT:DSS), Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP), Ibio Inc (NYSEMKT:IBIO)
Pain Therapeutics, Inc. (NASDAQ:PTIE) declined -14.26%, trading on 2.88 million shares, to end the trade at $4.39. The stock changed hands in a range of $4.19 to $5.00, bringing its market capitalization to about $199.47 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $2.15 and was moved to the maximum level of $5.57. Pain Therapeutics, Inc. is a biopharmaceutical company that develops drugs. The Company has four drug candidates in clinical programs, including REMOXY, abuse-resistant hydromorphone, abuse-resistant hydrocodone and a radio-labeled monoclonal antibody to treat metastatic melanoma.
Has PTIE Found The Bottom And Ready To Gain Momentum? Find Out Here
Document Security Systems, Inc. (NYSEMKT:DSS) declined -13.81%, to complete the trading session at $1.56, with a total volume of 3.49 million shares. The stock, on average, trades on a volume of 1.24 million shares. It floated in a range of $1.47 to $1.73 during the last trading session, with a beta value of 0.48. Its market capitalization now moved to about $76.80 million. In the past 52 weeks, the share price has not declined below $0.86 and above $3.64. Document Security Systems, Inc. (DSS) develops, markets, secure technologies. The Company specializes in fraud and counterfeit protection for all forms of printed documents and digital information. The Company holds numerous patents for optical deterrent technologies that provide protection of printed information from unauthorized scanning and copying.
Why Should Investors Buy DSS After the Recent Fall? Just Go Here and Find Out
Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) recorded a fall of -13.10% and was in a range of $21.25-$26.30 before closing at $22.95. The stock completed the day with a total volume of 1.33 million shares, versus an average volume of 795,321 shares. The share price hit its 52-week low of $5.00 and $31.73was the best price. Oramed Pharmaceuticals Inc. is a development-stage pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet to be used for the treatment of individuals with diabetes, use of orally ingestible capsules, tablets or pills for delivery of other polypeptides.
Will ORMP Get Buyers Even After The Recent Rally? Find Out Here
Ibio Inc (NYSEMKT:IBIO) declined -11.16% yesterday, bringing its market capitalization around $35.46 million. The share price, after opening at $0.57, made a high of $0.59 and hovered above $0.47 to end the day at $0.47. The total number of shares that changed hands during the session was 1.75 million shares, as compared to average trading volume of 290,284 shares. iBio, Inc. (iBio) is a biotechnology company focused on commercializing its technologies, the iBioLaunch platform for vaccines and therapeutic proteins, as well as the iBioModulator platform for vaccine enhancement. Vaccine candidates on its platform are applicable to newly emerging strains of hemagglutinin type 1 and neuraminidase type 1 (H1N1), swine-like influenza, hemagglutinin type 5 and neuraminidase type 1 (H5N1) avian influenza, yellow fever, and anthrax.
Will IBIO Bounce Back After yesterday’s Sharp Sell off? Find Out Here
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)